Literature DB >> 18772165

Tumour suppressor menin is essential for development of the pancreatic endocrine cells.

Sandra Fontanière1, Bertrand Duvillié, Raphaël Scharfmann, Christine Carreira, Zhao-Qi Wang, Chang-Xian Zhang.   

Abstract

Mutations of the multiple endocrine neoplasia type 1 (MEN1) gene predispose patients to MEN1 that affects mainly endocrine tissues, suggesting important physiological functions of the gene in adult endocrine cells. Homozygous disruption of Men1 in mice causes embryonic lethality, whereas the eventual involvement of the gene in embryonic development of the endocrine cells remains unknown. Here, we show that homozygous Men1 knockout mice demonstrate a reduced number of glucagon-positive cells in the E12.5 pancreatic bud associated with apoptosis, whereas the exocrine pancreas development in these mice is not affected. Our data suggest that menin is involved in the survival of the early pancreatic endocrine cells during the first developmental transition. Furthermore, chimerism assay revealed that menin has an autonomous and specific effect on the development of islet cells. In addition, using pancreatic bud culture mimicking the differentiation of alpha- and beta-cells during the second transition, we show that loss of menin leads to the failure of endocrine cell development, altered pancreatic structure and a markedly decreased number of cells expressing neurogenin 3, indicating that menin is also required at this stage of the endocrine pancreas development. Taken together, our results suggest that menin plays an indispensable role in the development of the pancreatic endocrine cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772165     DOI: 10.1677/JOE-08-0289

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

Review 1.  COMPASS and SWI/SNF complexes in development and disease.

Authors:  Bercin K Cenik; Ali Shilatifard
Journal:  Nat Rev Genet       Date:  2020-09-21       Impact factor: 53.242

Review 2.  Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.

Authors:  Koen M A Dreijerink; H T Marc Timmers; Myles Brown
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

Review 3.  Role of transcription factors in the transdifferentiation of pancreatic islet cells.

Authors:  Talitha van der Meulen; Mark O Huising
Journal:  J Mol Endocrinol       Date:  2015-04       Impact factor: 5.098

4.  MEN1 silencing aggravates tumorigenic potential of AR-independent prostate cancer cells through nuclear translocation and activation of JunD and β-catenin.

Authors:  Yakun Luo; Virginie Vlaeminck-Guillem; Silvère Baron; Sarah Dallel; Chang Xian Zhang; Muriel Le Romancer
Journal:  J Exp Clin Cancer Res       Date:  2021-08-26

5.  Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass.

Authors:  Latif Rachdi; Dulanjalee Kariyawasam; Fanny Guez; Virginie Aïello; Maria L Arbonés; Nathalie Janel; Jean-Maurice Delabar; Michel Polak; Raphaël Scharfmann
Journal:  Diabetologia       Date:  2014-01-30       Impact factor: 10.122

6.  Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors.

Authors:  Sunita K Agarwal; Raja Jothi
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

7.  Computational analysis of human and mouse CREB3L4 Protein.

Authors:  Kiran Kumar Velpula; Azeem Abdul Rehman; Soumya Chigurupati; Ramadevi Sanam; Krishna Kishore Inampudi; Chandra Sekhar Akila
Journal:  Bioinformation       Date:  2012-06-28

8.  Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors.

Authors:  Yasutaka Takeda; Yukihiro Fujita; Kentaro Sakai; Tomoe Abe; Tomonobu Nakamura; Tsuyoshi Yanagimachi; Hidemitsu Sakagami; Jun Honjo; Atsuko Abiko; Yuichi Makino; Masakazu Haneda
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-09-04

Review 9.  Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Biomark Insights       Date:  2018-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.